Cargando…
Enhancement of tumor lethality of ROS in photodynamic therapy
In the process of photodynamic therapy (PDT) treatment of tumors, reactive oxygen species (ROS) plays a key role in destroying tumor tissues. However, traditional PDT often has limited ROS killing capacity due to hypoxia in the tumor microenvironment (TME) or obstruction by the ROS defense system, r...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826450/ https://www.ncbi.nlm.nih.gov/pubmed/33141513 http://dx.doi.org/10.1002/cam4.3592 |
_version_ | 1783640523133681664 |
---|---|
author | Ming, Lan Cheng, Kai Chen, Yu Yang, Rui Chen, Daozhen |
author_facet | Ming, Lan Cheng, Kai Chen, Yu Yang, Rui Chen, Daozhen |
author_sort | Ming, Lan |
collection | PubMed |
description | In the process of photodynamic therapy (PDT) treatment of tumors, reactive oxygen species (ROS) plays a key role in destroying tumor tissues. However, traditional PDT often has limited ROS killing capacity due to hypoxia in the tumor microenvironment (TME) or obstruction by the ROS defense system, resulting in poor efficacy. Therefore, enhancing the killing effect of ROS on tumors is the core of enhancing the anti‐tumor effect of PDT. In recent years, many studies have developed a series of strategies to enhance the ability of ROS to kill tumors in view of the limitations of the TME on PDT. This article summarizes the commonly used or innovative strategies in recent years, including not only frequently used methods for hypoxia in the TME but also innovative strategies to inhibit the ROS defense system. |
format | Online Article Text |
id | pubmed-7826450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78264502021-02-01 Enhancement of tumor lethality of ROS in photodynamic therapy Ming, Lan Cheng, Kai Chen, Yu Yang, Rui Chen, Daozhen Cancer Med Cancer Biology In the process of photodynamic therapy (PDT) treatment of tumors, reactive oxygen species (ROS) plays a key role in destroying tumor tissues. However, traditional PDT often has limited ROS killing capacity due to hypoxia in the tumor microenvironment (TME) or obstruction by the ROS defense system, resulting in poor efficacy. Therefore, enhancing the killing effect of ROS on tumors is the core of enhancing the anti‐tumor effect of PDT. In recent years, many studies have developed a series of strategies to enhance the ability of ROS to kill tumors in view of the limitations of the TME on PDT. This article summarizes the commonly used or innovative strategies in recent years, including not only frequently used methods for hypoxia in the TME but also innovative strategies to inhibit the ROS defense system. John Wiley and Sons Inc. 2020-11-03 /pmc/articles/PMC7826450/ /pubmed/33141513 http://dx.doi.org/10.1002/cam4.3592 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Biology Ming, Lan Cheng, Kai Chen, Yu Yang, Rui Chen, Daozhen Enhancement of tumor lethality of ROS in photodynamic therapy |
title | Enhancement of tumor lethality of ROS in photodynamic therapy |
title_full | Enhancement of tumor lethality of ROS in photodynamic therapy |
title_fullStr | Enhancement of tumor lethality of ROS in photodynamic therapy |
title_full_unstemmed | Enhancement of tumor lethality of ROS in photodynamic therapy |
title_short | Enhancement of tumor lethality of ROS in photodynamic therapy |
title_sort | enhancement of tumor lethality of ros in photodynamic therapy |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826450/ https://www.ncbi.nlm.nih.gov/pubmed/33141513 http://dx.doi.org/10.1002/cam4.3592 |
work_keys_str_mv | AT minglan enhancementoftumorlethalityofrosinphotodynamictherapy AT chengkai enhancementoftumorlethalityofrosinphotodynamictherapy AT chenyu enhancementoftumorlethalityofrosinphotodynamictherapy AT yangrui enhancementoftumorlethalityofrosinphotodynamictherapy AT chendaozhen enhancementoftumorlethalityofrosinphotodynamictherapy |